SCHEMBL22280017

SCHEMBL22280017

CC(CN(C)C)CS(N)(=O)=NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20760555 0.73 CA1 (0.34) —
SCHEMBL11021800 0.69 SLC22A6 (0.34) —
SCHEMBL1724699 0.65 GAA (0.33) —
SCHEMBL24969009 0.62 — —
SCHEMBL28240410 0.62 ALOX15 (0.40) —
SCHEMBL23516732 0.61 — —
SCHEMBL26314580 0.61 — —
SCHEMBL26315040 0.61 CA12 (0.30) —
SCHEMBL20744183 0.60 CA2 (0.32) —
SCHEMBL16013532 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154321-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 — — WO disclosed
Send feedback